US Specialty Drug Distribution Market Research Report 2022-2027: Market Set to Grow to $747.03 Million By 2027 with Compound Annual Growth at 13.99% – ResearchAndMarkets.com

US Specialty Drug Distribution Market Research Report 2022-2027: Market Set to Grow to $747.03 Million By 2027 with Compound Annual Growth at 13.99% – ResearchAndMarkets.com




US Specialty Drug Distribution Market Research Report 2022-2027: Market Set to Grow to $747.03 Million By 2027 with Compound Annual Growth at 13.99% – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Specialty Drug Distribution Market Research Report by Indication (AIDS, Hemophilia, and Multiple Sclerosis), Type, Distribution Type, Distribution Channel, State – United States Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering.

The United States Specialty Drug Distribution Market size was estimated at USD 340.41 million in 2021 and expected to reach USD 386.97 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 13.99% to reach USD 747.03 million by 2027.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Specialty Drug Distribution Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section delivers valuable thoughts at the different stages while keeping up-to-date with the business and engages stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition & Expansion. All the news collected helps vendor to understand the gaps in the marketplace and competitors’ strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Specialty Drug Distribution Market, including Anda, Inc., Avella Specialty Pharmacy, Biologics, Inc., CuraScript, Inc., CVS Health Corporation, Diplomat Pharmacy, Inc., Express Scripts Holding Company, Greenhill & Co., Inc., and Pfizer Inc.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

Key Topics Covered:

1. Preface

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics

5.1.1. Drivers

5.1.2. Restraints

5.1.3. Opportunities

5.1.4. Challenges

5.2. Cumulative Impact of COVID-19

6. Specialty Drug Distribution Market, by Indication

6.1. Introduction

6.2. AIDS

6.3. Hemophilia

6.4. Multiple Sclerosis

6.5. Oncology

6.6. Rheumatoid Arthritis

7. Specialty Drug Distribution Market, by Type

7.1. Introduction

7.2. Full line Wholesalers

7.3. Specialty Distributors

8. Specialty Drug Distribution Market, by Distribution Type

8.1. Introduction

8.2. Clinic/ASCs

8.3. Home Health

8.4. Inpatient

8.5. Mail Delivery

8.6. Outpatient

8.7. Retail

9. Specialty Drug Distribution Market, by Distribution Channel

9.1. Introduction

9.2. Hospitals & Care Providers

9.3. Independent Pharmacies

9.4. Large Chain Pharmacies

9.5. Online Stores

9.6. Specialty Pharmacies

10. California Specialty Drug Distribution Market

11. Florida Specialty Drug Distribution Market

12. Illinois Specialty Drug Distribution Market

13. New York Specialty Drug Distribution Market

14. Ohio Specialty Drug Distribution Market

15. Pennsylvania Specialty Drug Distribution Market

16. Texas Specialty Drug Distribution Market

17. Competitive Landscape

17.1. FPNV Positioning Matrix

17.1.1. Quadrants

17.1.2. Business Strategy

17.1.3. Product Satisfaction

17.2. Market Ranking Analysis

17.3. Market Share Analysis, By Key Player

17.4. Competitive Scenario

17.4.1. Merger & Acquisition

17.4.2. Agreement, Collaboration, & Partnership

17.4.3. New Product Launch & Enhancement

17.4.4. Investment & Funding

17.4.5. Award, Recognition, & Expansion

Companies Mentioned

  • Anda, Inc.
  • Avella Specialty Pharmacy
  • Biologics, Inc.
  • CuraScript, Inc.
  • CVS Health Corporation
  • Diplomat Pharmacy, Inc.
  • Express Scripts Holding Company
  • Greenhill & Co., Inc.
  • Pfizer Inc.

For more information about this report visit https://www.researchandmarkets.com/r/ta8uw3

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900